Patents by Inventor Jeffrey Wojton

Jeffrey Wojton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods useful for treating glioblastoma
    Patent number: 11660329
    Abstract: The present invention provides compositions and methods useful for treating cancers such as glioblastoma. SapC-DOPS was found to be synergistically effective at inducing cell death when administered in conjunction with rampamycin. SapC-DOPS/rapamycin combination therapy allows physicians to give lower doses of each drug and achieve better therapeutic efficacy. The compositions also allow for less toxicity and fewer off-target effects. Related methods and materials are also provided herein.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: May 30, 2023
    Assignees: University of Cincinnati, Ohio State Innovation Foundation
    Inventors: Balveen Kaur, Jeffrey Wojton, Xiaoyang Qi
  • Materials and Methods Useful For Treating Glioblastoma
    Publication number: 20170340715
    Abstract: The present invention provides compositions and methods useful for treating cancers such as glioblastoma. SapC-DOPS was found to be synergistically effective at inducing cell death when administered in conjunction with rampamycin. SapC-DOPS/rapamycin combination therapy allows physicians to give lower doses of each drug and achieve better therapeutic efficacy. The compositions also allow for less toxicity and fewer off-target effects. Related methods and materials are also provided herein.
    Type: Application
    Filed: August 9, 2017
    Publication date: November 30, 2017
    Applicants: Ohio State Innovation Foundation, University of Cincinnati
    Inventors: Balveen Kaur, Jeffrey Wojton, Xiaoyang Qi
  • Materials and methods useful for treating glioblastorna
    Patent number: 9757432
    Abstract: The present invention provides compositions and methods useful for treating cancers such as glioblastoma. SapC-DOPS was found to be synergistically effective at inducing cell death when administered in conjunction with rapamycin. SapC-DOPS/rapamycin combination therapy allows physicians to give lower doses of each drug and achieve better therapeutic efficacy. The compositions also allow for less toxicity and fewer off-target effects. Related methods and materials are also provided herein.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: September 12, 2017
    Assignees: Ohio State Innovation Foundation, University of Cincinnati
    Inventors: Balveen Kaur, Jeffrey Wojton, Xiaoyang Qi
  • Materials and Methods Useful for Treating Glioblastoma
    Publication number: 20150290300
    Abstract: The present invention provides compositions and methods useful for treating cancers such as glioblastoma. SapC-DOPS was found to be synergistically effective at inducing cell death when administered in conjunction with rapamycin. SapC-DOPS/rapamycin combination therapy allows physicians to give lower doses of each drug and achieve better therapeutic efficacy. The compositions also allow for less toxicity and fewer off-target effects. Related methods and materials are also provided herein.
    Type: Application
    Filed: November 14, 2013
    Publication date: October 15, 2015
    Applicants: University of Cincinnati, Ohio State Innovation Foundation
    Inventors: Balveen Kaur, Jeffrey Wojton, Xiaoyang Qi